BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6432877)

  • 1. Arachidonate 5-lipoxygenase and its new inhibitors.
    Yamamoto S; Yoshimoto T; Furukawa M; Horie T; Watanabe-Kohno S
    J Allergy Clin Immunol; 1984 Sep; 74(3 Pt 2):349-52. PubMed ID: 6432877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent and selective 5-lipoxygenase inhibitors: cirsiliol and AA-861.
    Kohno SW; Ohata K; Maki Y; Horie T; Yoshimoto T; Yamamoto S
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():217-9. PubMed ID: 2936097
    [No Abstract]   [Full Text] [Related]  

  • 3. 2,3,5-Trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone (AA861), a selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxis.
    Yoshimoto T; Yokoyama C; Ochi K; Yamamoto S; Maki Y; Ashida Y; Terao S; Shiraishi M
    Biochim Biophys Acta; 1982 Nov; 713(2):470-3. PubMed ID: 6817808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flavonoids: potent inhibitors of arachidonate 5-lipoxygenase.
    Yoshimoto T; Furukawa M; Yamamoto S; Horie T; Watanabe-Kohno S
    Biochem Biophys Res Commun; 1983 Oct; 116(2):612-8. PubMed ID: 6418162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on arachidonate 5-lipoxygenase of rat basophilic leukemia cells.
    Furukawa M; Yoshimoto T; Ochi K; Yamamoto S
    Biochim Biophys Acta; 1984 Oct; 795(3):458-65. PubMed ID: 6089906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arachidonate 5-lipoxygenase inhibitors show potent antiproliferative effects on human leukemia cell lines.
    Tsukada T; Nakashima K; Shirakawa S
    Biochem Biophys Res Commun; 1986 Nov; 140(3):832-6. PubMed ID: 3778487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arachidonate 5-lipoxygenase of guinea pig peritoneal polymorphonuclear leukocytes. Activation by adenosine 5'-triphosphate.
    Ochi K; Yoshimoto T; Yamamoto S; Taniguchi K; Miyamoto T
    J Biol Chem; 1983 May; 258(9):5754-8. PubMed ID: 6406506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profile of AA-861, a 5-lipoxygenase inhibitor.
    Ashida Y; Saijo T; Kuriki H; Makino H; Terao S; Maki Y
    Prostaglandins; 1983 Dec; 26(6):955-72. PubMed ID: 6084855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lipoxygenase inhibitors, AA-861 and T-22083, on chemical mediators released from sensitized guinea-pig lung tissue.
    Ishihara Y; Kitamura S; Takaku F
    Prostaglandins; 1983 Oct; 26(4):623-9. PubMed ID: 6419291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pure enzymes in a test hierarchy for antibronchoconstrictory lipoxygenase inhibitors.
    Slapke J; Schewe T; Kühn H; Rapoport SM
    Biomed Biochim Acta; 1986; 45(10):1267-75. PubMed ID: 3105528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular localization of leukotriene-forming enzymes.
    Jakschik BA; Kuo CG
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():141-5. PubMed ID: 6221516
    [No Abstract]   [Full Text] [Related]  

  • 12. Purification, characterization, and structural properties of a single protein from rat basophilic leukemia (RBL-1) cells possessing 5-lipoxygenase and leukotriene A4 synthetase activities.
    Hogaboom GK; Cook M; Newton JF; Varrichio A; Shorr RG; Sarau HM; Crooke ST
    Mol Pharmacol; 1986 Dec; 30(6):510-9. PubMed ID: 3785138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 5-lipoxygenase inhibition on cardiac anaphylaxis in isolated guinea pig hearts.
    Jolly SR; Travis J; Van Inwegen RG
    Pharmacology; 1989; 38(6):352-62. PubMed ID: 2813496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of human mast cells and basophils. Effects of a putative 5-lipoxygenase inhibitor.
    Cohan V; McKenzie-White J; Triggiani M; Massey W; Kagey-Sobotka A; Lichtenstein LM
    Biochem Pharmacol; 1989 Dec; 38(24):4455-9. PubMed ID: 2481451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models.
    Ku EC; Raychaudhuri A; Ghai G; Kimble EF; Lee WH; Colombo C; Dotson R; Oglesby TD; Wasley JW
    Biochim Biophys Acta; 1988 Apr; 959(3):332-42. PubMed ID: 2833314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arachidonic acid-15-lipoxygenase from rabbit peritoneal polymorphonuclear leukocytes.
    Narumiya S; Salmon JA
    Methods Enzymol; 1982; 86():45-8. PubMed ID: 6813644
    [No Abstract]   [Full Text] [Related]  

  • 17. Specific inhibition and oxidative regulation of 5-lipoxygenase.
    Egan RW; Tischler AN; Baptista EM; Ham EA; Soderman DD; Gale PH
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():151-7. PubMed ID: 6221519
    [No Abstract]   [Full Text] [Related]  

  • 18. Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids.
    Moroney MA; Alcaraz MJ; Forder RA; Carey F; Hoult JR
    J Pharm Pharmacol; 1988 Nov; 40(11):787-92. PubMed ID: 2907559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium stimulation of the 5-lipoxygenase from RBL-1 cells.
    Parker CW; Aykent S
    Biochem Biophys Res Commun; 1982 Dec; 109(3):1011-6. PubMed ID: 6818963
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiallergic activity of AA-861, a 5-lipoxygenase inhibitor.
    Maki Y; Ashida Y; Makino H; Saijo T; Kuriki H; Terao S
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():349-51. PubMed ID: 2868625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.